Skip to main content
Top
Published in: World Journal of Surgery 10/2015

01-10-2015 | Original Scientific Report

Long-Term Outcome of IPAA in Patients Presenting with Fulminant Ulcerative Colitis: A Matched Cohort Study

Authors: Geoffrey S. Fasen, T. K. Pandian, Emily S. Pavey, Eric J. Dozois, Sarah Y. Boostrom

Published in: World Journal of Surgery | Issue 10/2015

Login to get access

Abstract

Background

Studies reveal that ileal pouch-anal anastomosis (IPAA) has long-term success. These reports, however, use well-selected cohorts and exclude patients presenting with fulminant colitis (FC). Herein, we aimed to characterize long-term functional outcomes in patients with fulminant ulcerative colitis (UC) undergoing IPAA.

Methods

A prospective database identified patients who underwent IPAA between 1998 and 2008. Patients with FC and chronic UC were matched by age, gender, date of surgery, and follow-up duration. Clinical and laboratory parameters, immunomodulator use at the time of surgery, and functional outcomes were compared.

Results

Forty patients with FC and 73 patients with chronic UC were identified. Preoperative albumin, hemoglobin, leukocyte count, and steroid dose were significantly different for those with FC. Average survey follow-up was 5.2 years for FC and 6.7 years for chronic UC patients. Functional outcomes were not significantly different. The 3-year fistula-free rate was 91.4 versus 98.6 % and the 3-year stricture-free rate was 79.3 versus 87.2 % for FC versus chronic UC patients, respectively.

Conclusion

Patients undergoing colectomy for FC secondary to UC have similar long-term functional outcomes after IPAA despite significantly worse presentation. This study confirms that IPAA is an appropriate and durable treatment for patients with FC.
Literature
1.
go back to reference Hahnloser D et al (2007) Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg 94(3):333–340CrossRefPubMed Hahnloser D et al (2007) Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg 94(3):333–340CrossRefPubMed
2.
go back to reference Michelassi F et al (2003) Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg 238(3):433–441 (discussion 442–445)PubMedCentralPubMed Michelassi F et al (2003) Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg 238(3):433–441 (discussion 442–445)PubMedCentralPubMed
3.
go back to reference Rokke O et al (2011) Long-term followup with evaluation of the surgical and functional results of the ileal pouch reservoir in restorative proctocolectomy for ulcerative colitis. ISRN Gastroenterol 2011:625842PubMedCentralPubMed Rokke O et al (2011) Long-term followup with evaluation of the surgical and functional results of the ileal pouch reservoir in restorative proctocolectomy for ulcerative colitis. ISRN Gastroenterol 2011:625842PubMedCentralPubMed
5.
7.
go back to reference Ziv Y et al (1995) Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis. Dis Colon Rectum 38(4):345–349CrossRefPubMed Ziv Y et al (1995) Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis. Dis Colon Rectum 38(4):345–349CrossRefPubMed
8.
go back to reference Harms BA et al (1994) Management of fulminant ulcerative colitis by primary restorative proctocolectomy. Dis Colon Rectum 37(10):971–978CrossRefPubMed Harms BA et al (1994) Management of fulminant ulcerative colitis by primary restorative proctocolectomy. Dis Colon Rectum 37(10):971–978CrossRefPubMed
9.
go back to reference Holubar SD et al (2009) Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum 52(2):187–192CrossRefPubMed Holubar SD et al (2009) Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum 52(2):187–192CrossRefPubMed
10.
go back to reference Hoda KM et al (2008) Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. Dis Colon Rectum 51(5):554–560CrossRefPubMed Hoda KM et al (2008) Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. Dis Colon Rectum 51(5):554–560CrossRefPubMed
11.
go back to reference Heuschen UA et al (2002) Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 235(2):207–216PubMedCentralCrossRefPubMed Heuschen UA et al (2002) Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 235(2):207–216PubMedCentralCrossRefPubMed
12.
go back to reference Jarnerot G et al (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128(7):1805–1811CrossRefPubMed Jarnerot G et al (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128(7):1805–1811CrossRefPubMed
13.
go back to reference Ferrante M et al (2008) Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns Colitis 2(3):219–225CrossRefPubMed Ferrante M et al (2008) Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns Colitis 2(3):219–225CrossRefPubMed
14.
go back to reference Reinisch W et al (2012) Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. J Crohns Colitis 6(2):248–258CrossRefPubMed Reinisch W et al (2012) Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. J Crohns Colitis 6(2):248–258CrossRefPubMed
15.
go back to reference Selvasekar CR et al (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204(5):956–962 (discussion 962–963)CrossRefPubMed Selvasekar CR et al (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204(5):956–962 (discussion 962–963)CrossRefPubMed
16.
go back to reference Mor IJ et al (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51(8):1202–1207 (discussion 1207–1210)CrossRefPubMed Mor IJ et al (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51(8):1202–1207 (discussion 1207–1210)CrossRefPubMed
17.
go back to reference Kunitake H et al (2008) Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 12(10):1730–1736 (discussion 1736–1737)CrossRefPubMed Kunitake H et al (2008) Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 12(10):1730–1736 (discussion 1736–1737)CrossRefPubMed
Metadata
Title
Long-Term Outcome of IPAA in Patients Presenting with Fulminant Ulcerative Colitis: A Matched Cohort Study
Authors
Geoffrey S. Fasen
T. K. Pandian
Emily S. Pavey
Eric J. Dozois
Sarah Y. Boostrom
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 10/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3114-5

Other articles of this Issue 10/2015

World Journal of Surgery 10/2015 Go to the issue